Diabetes Drug Metformin Could Cut Risks for Long COVID-19
Diabetes drug metformin has shown promising results in reducing the risk of long COVID-19, according to a new study published in The Lancet Infectious Diseases. This breakthrough offers hope to millions of people around the world who are grappling with the lingering effects of COVID-19. Metformin, widely used to manage type 2 diabetes, is now … Read more